The DOI matches its Crossref record; 164 of the 176 references it cites were found in a registry or an index.
TGF-β3 and cancer: A review
Open accessAbstract
With the development of growth factors and growth factor modulators as therapeutics for a range of disorders, it is prudent to consider whether modulating the growth factor profile in a tissue can influence tumour initiation or progression. As recombinant human TGF-beta3 (avotermin) is being developed for the improvement of scarring in the skin it is important to understand the role, if any, of this cytokine in tumour progression. Elevated levels of TGF-beta3 expression detected in late-stage tumours have linked this cytokine with tumourigenesis, although functional data to support a causative role are lacking. While it has proved tempting for researchers to interpret a 'correlation' as a 'cause' of disease, what has often been overlooked is the normal biological role of TGF-beta3 in processes that are often subverted in tumourigenesis. Clarifying the role of this cytokine is complicated by inappropriate extrapolation of the data relating to TGF-beta1 in tumourigenesis, despite marked differences in biology between the TGF-beta isoforms. Indeed, published studies have indicated that TGF-beta3 may actually play a protective role against tumourigenesis in a range of tissues including the skin, breast, oral and gastric mucosa. Based on currently available data it is reasonable to hypothesize that administration of acute low doses of exogenous TGF-beta3 is unlikely to influence tumour initiation or progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, a TβRII receptor antibody (IMC-TRI, LY3022859) under development by Eli Lilly showed efficacy in preclinical evaluation against mammary cancer304”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [304]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., Veer, L. V. ‘., Dai, H. A., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,474
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Balch, C. M., Buzaid, A. C., Soong, S., Atkins, M. B., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A. N., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3635 · Cited by 2,627
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Sotiriou, C. P., Wirapati, P., Loi, S., Harris, A. L., Fox, S., Smeds, J., Nordgren, H., Farmer, P. J., Praz, V., Haibe‐Kains, B., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,050
Research works printed but not linked: 1
- MacDougall, 1993, Responsiveness of normal dysplastic melanocytes and melanoma cells from different lesional stages of disease progression to the growth inhibitory effects of TGF-b, Mol Cell Different, 1, 21
Cited by
Sorted by citations
Items 101–111 of 111
Effects of Bone Marrow Sparing and TGF-β3 Treatment in Total Body Irradiation of C57BL/6J Mice
Hanson, I., Vatne, J. T., & Edin, N. F. J. (2024) · Applied Biosciences · doi:10.3390/applbiosci3020011
Poulet, S., Dai, M., Wang, N., Yan, G., Boudreault, J., Daliah, G., Guillevin, A., Nguyen, H., Galal, S., Ali, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25963250
Poulet, S., Dai, M., Wang, N., Yan, G., Boudreault, J., Daliah, G., Guillevin, A., Nguyen, H., Galal, S., Ali, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26728945
Poulet, S., Dai, M., Wang, N., Yan, G., Boudreault, J., Daliah, G., Guillevin, A., Nguyen, H., Galal, S., Ali, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25963049
Yeon, E., Kang, D., Kang, T., Song, H., & Jiyoung, K. I. M. (2025) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2025.31.4.279
Sheikh, W. M., Mehreen, S., Mehraj, I., Jan, J., Hyderi, Z., Rather, B. A., Rafique, A., Shah, U. S., Jadhav, I., Samadh, Y. A., et al. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-23908-3.00005-8
Katagiri, S., Itaya, T., Sano, M., Kiuchi, N., Toyoshima, Y., Takagi, S., & Suzuki, T. (2026) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-026-03860-0
Akkour, K., Rafiullah, M., Masood, A., Alanazi, I. O., Alfadda, A. A., Joy, S. S., Bassi, A., Alhalal, H., Alshehri, E., Arafah, M., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1759839
Lariz, F. J., Bautista-Tovar, D. C., Lazo-Loya, A., & Houston, K. D. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1856096
Kappenman, D. L., Koehler, C. L., Prentice, R. N., Koziar, N., Beardow, A., Merlo, A., Knauer, C. S., Mwangi, D. M., & Stirling, C. M. A. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1885917
The role of type I Interferon in v-abl induced leukemia
Moritz, N. (2010) · University of Vienna · doi:10.25365/thesis.12845
Metadata
- Authors
- Laverty, H. G., Wakefield, L. M., Occleston, N. L., O’Kane, S., & Ferguson, M. W. J.
- Affiliations
- Renovo (United Kingdom) (GB)
- National Institutes of Health (US)
- Corresponding author
- Ferguson, M.W.J.
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 20
- Issue
- 4
- Pages
- 305-317
- ISSN
- 1359-6101 (ISSN-L)
- PMC
- PMC7294566
- OpenAlex
- W2025475845
- Cited by
- 110
- References
- 176
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 12 · 2023: 8 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 2 · 2018: 9 · 2017: 9 · 2016: 8 · 2015: 8 · 2014: 3 · 2013: 6 · 2012: 9
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cytokine & Growth Factor Reviews (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (Z01BC010881)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- TGF-beta3, tumourigenesis, tumor progression, TGF-beta isoforms, TGF-β1, growth factor therapy, tumor suppression, scar tissue, breast cancer, oral mucosa, gastric mucosa
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Models, Molecular, Molecular Conformation, Molecular Sequence Data, Neoplasms, Sequence Homology, Amino Acid, Protein Isoforms, Transforming Growth Factor beta3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
